Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06942936 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 51
- Enrollment target
NCT06942936 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 51 participants.
The verdict
NCT06942936, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of multiple doses of itraconazole on the pharmacokinetics (PK) of AZD5004 in healthy participants (Part A), and to assess the impact of multiple doses of AZD5004 on the PK of Combined Oral Contraceptives (COCs) in healthy female participants (Part B).
Interventions
- DRUG Itraconazole
- DRUG AZD5004
- DRUG EE/LNG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2025-05-28 |
| Est. Completion | 2026-01-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06942936
The ClinicalTrials.gov registry entry for NCT06942936 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Itraconazole is the first listed.
NCT06942936 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06942936 about?
NCT06942936 is a clinical study titled "A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants". The purpose of this study is to assess the impact of multiple doses of itraconazole on the pharmacokinetics (PK) of AZD5004 in healthy participants (Part A), and to assess the impact of multiple doses of AZD5004 on the PK of Combined Oral Contraceptives (COCs) in healthy female participants (Part B)...
What is the current status of trial NCT06942936?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 51 participants. The study started on 2025-05-28. Estimated completion is 2026-01-28.
What interventions are being tested in trial NCT06942936?
The interventions under investigation include: Itraconazole (DRUG), AZD5004 (DRUG), EE/LNG (DRUG).
Who is sponsoring clinical trial NCT06942936?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.